| 1392315-38-6 Basic information More.. |
Product Name: | (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-((tert-butoxycarbonyl)amino)-5 a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl trifluoromethanesulfonate | Synonyms: | (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-((tert-butoxycarbonyl)amino)-5 a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl trifluoromethanesulfonate;EOS-61827;28-Norlupa-2,20(29)-dien-3-ol, 17-[[(1,1-dimethylethoxy)carbonyl]amino]-, 3-(1,1,1-trifluoromethanesulfonate) | CAS: | 1392315-38-6 | MF: | C35H54F3NO5S | MW: | 657.87 | EINECS: | | Mol File: | 1392315-38-6.mol | |
|
1392315-38-6
Recommend Suppliers |
Company Name: |
Dezhou LonWel Pharmaceutical Technology Co., Ltd.
Recommend
Complaint |
|
Tel: |
|
FAX: |
QQ: 39324283 |
Email: |
39324283@qq.com |
Products Intro: |
Product Name:(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-((tert-butoxycarbonyl)amino)-5 a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl trifluoromethanesulfonate CAS:1392315-38-6 Purity:97%HPLC Package:1KG
More... |
CB Index: |
58 |
WebSite: |
https://www.chemicalbook.com/ShowSupplierProductsList20080/0.htm |
Related Information: |
Sales Network
Catalog(1991)
User Evaluation
|
Company Name: |
Shanghai zhigan biotechnology co., LTD
Recommend
Complaint |
|
Tel: |
|
FAX: |
|
Email: |
zhiqianbio@126.com |
Products Intro: |
Product Name:(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-((tert-butoxycarbonyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-En-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[aChrysen-9-yltrifluoromethanesulfonate CAS:1392315-38-6 Purity:99% HPLC Package:100G;500G;1KG
More... |
CB Index: |
58 |
WebSite: |
www.chemicalbook.com/ShowSupplierProductsList31144/0.htm |
Related Information: |
Sales Network
Catalog(19778)
User Evaluation(1)
|
1
|